Masimo Corporation logo

Masimo Corporation (MASI)

Market Closed
23 Feb, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
175. 25
+0.15
+0.09%
$
9.41B Market Cap
68.52 P/E Ratio
5.8% Div Yield
2,268,001 Volume
2.91 Eps
$ 175.1
Previous Close
Day Range
175.2 175.69
Year Range
125.94 194.88
Want to track MASI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MASI earnings report is expected in 2 days (26 Feb 2026)
Why Masimo (MASI) is a Top Growth Stock for the Long-Term

Why Masimo (MASI) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 4 months ago
Masimo Completes Divestment of Consumer Audio Business to HARMAN

Masimo Completes Divestment of Consumer Audio Business to HARMAN

MASI completes sale of Sound United to HARMAN, sharpening focus on core healthcare, boosting margins, and funding buybacks.

Zacks | 5 months ago
Here's Why Masimo (MASI) is a Strong Growth Stock

Here's Why Masimo (MASI) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 5 months ago
Here is Why Growth Investors Should Buy Masimo (MASI) Now

Here is Why Growth Investors Should Buy Masimo (MASI) Now

Masimo (MASI) could produce exceptional returns because of its solid growth attributes.

Zacks | 6 months ago
Why Masimo (MASI) is a Top Growth Stock for the Long-Term

Why Masimo (MASI) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 6 months ago
Masimo sues US Customs over approval of Apple Watch imports

Masimo sues US Customs over approval of Apple Watch imports

Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple to import Apple Watches with blood-oxygen reading technology during a patent dispute between the companies.

Reuters | 6 months ago
Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring

Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring

MASI gains FDA clearance to expand O3 monitoring with delta hemoglobin parameters across all patient groups.

Zacks | 6 months ago
3 Reasons Why Growth Investors Shouldn't Overlook Masimo (MASI)

3 Reasons Why Growth Investors Shouldn't Overlook Masimo (MASI)

Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 6 months ago
MASI Stock Slips Despite Q2 Earnings and Revenue Beat, Margins Expand

MASI Stock Slips Despite Q2 Earnings and Revenue Beat, Margins Expand

Masimo's second-quarter 2025 performance beats earnings and revenue estimates, expands margins and lifts 2025 outlook.

Zacks | 6 months ago
Masimo Corporation (MASI) Q2 2025 Earnings Call Transcript

Masimo Corporation (MASI) Q2 2025 Earnings Call Transcript

Masimo Corporation (NASDAQ:MASI ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Catherine M. Szyman - CEO & Director Eli Kammerman - Vice President of Business Development & Investor Relations Micah Young - Chief Financial Officer Conference Call Participants Frederick Allen Wise - Stifel, Nicolaus & Company, Incorporated, Research Division Jason M.

Seekingalpha | 6 months ago
Masimo (MASI) Beats Q2 Earnings and Revenue Estimates

Masimo (MASI) Beats Q2 Earnings and Revenue Estimates

Masimo (MASI) came out with quarterly earnings of $1.33 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $0.86 per share a year ago.

Zacks | 6 months ago
Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think "Yes"

Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think "Yes"

Masimo (MASI) could produce exceptional returns because of its solid growth attributes.

Zacks | 9 months ago
Loading...
Load More